{
    "2018-07-16": [
        [
            {
                "time": "2018-07-18",
                "original_text": "Novartis’s Q2 2018 Estimates: Innovative Medicines Business",
                "features": {
                    "keywords": [
                        "Q2",
                        "Innovative Medicines",
                        "Business"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Segment-Wise Expectations for Novartis in Q2 2018",
                "features": {
                    "keywords": [
                        "Segment-Wise",
                        "Expectations",
                        "Q2",
                        "2018"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Expectations from Novartis’s Q2 2018 Earnings",
                "features": {
                    "keywords": [
                        "Expectations",
                        "Q2",
                        "Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Johnson & Johnson",
                        "Novartis",
                        "UnitedHealth",
                        "Microsoft"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Is a Surprise in the Cards for Novartis in Q2 Earnings?",
                "features": {
                    "keywords": [
                        "Surprise",
                        "Q2",
                        "Earnings"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "FDA Recalls Valsartan Drugs on Impurity Concerns: Teva Fell 1.8%",
                "features": {
                    "keywords": [
                        "FDA",
                        "Recalls",
                        "Valsartan",
                        "Drugs",
                        "Impurity",
                        "Teva"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "The Swiss Stock Market Finished Slightly Lower In Choppy Trade",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Lower",
                        "Choppy",
                        "Trade"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "Novartis had ‘longer and more detailed’ relationship with Trump lawyer Michael Cohen, Senate report finds",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Trump",
                        "lawyer",
                        "Michael Cohen",
                        "Senate",
                        "report"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "politics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-18",
                "original_text": "This Week's Biotech IPOs",
                "features": {
                    "keywords": [
                        "Week's",
                        "Biotech",
                        "IPOs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}